Ad
related to: research analyst
Search results
Financial Services Roundup: Market Talk
The Wall Street Journal· 33 minutes agoThe Dutch payment company’s 40% increase in sales force since the end of 2021 should lead to more wins, analysts Frederic Boulan and Aditya Buddhavarapu...
Should You Investigate ACM Research, Inc. (NASDAQ:ACMR) At US$24.09?
Simply Wall St. via Yahoo Finance· 1 hour agoACM Research, Inc. (NASDAQ:ACMR), is not the largest company out there, but it saw a double-digit...
The Zacks Analyst Blog Highlights Qualcomm, Alibaba, HSBC and PrimeEnergy Resources
Zacks via Yahoo Finance· 5 hours agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
High Rates to Support BNY Mellon's (BK) Top Line Amid Cost Woes
Zacks via Yahoo Finance· 2 hours agoThe company’s business transformation plan will likely bolster market share. Analysts seem...
The Zacks Analyst Blog Highlights Goldman Sachs, Wells Fargo, Walmart, Crane and Ingersoll Rand
Zacks via Yahoo Finance· 5 hours agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Research Analysts Offer Predictions for High Tide Inc.’s FY2025 Earnings (NASDAQ:HITI)
ETF DAILY NEWS· 14 hours agoHigh Tide Inc. (NASDAQ:HITI – Free Report) – Roth Capital reduced their FY2025 earnings estimates...
Bernstein analysts expect $200K Bitcoin price by 2025 due to spot BTC ETF flows
The Cointelegraph· 55 minutes agoAnalysts at research and brokerage firm Bernstein predict that Bitcoin (BTC) could reach nearly $200,000 by the end of next year, following strong inflows ...
Analysts Set BankUnited, Inc. (NYSE:BKU) PT at $30.50
ETF DAILY NEWS· 14 hours ago(NYSE:BKU – Get Free Report) has been assigned an average rating of “Reduce” from the nine ratings firms that are presently covering the firm, MarketBeat.com reports. Two equities research ...
William Blair Research Analysts Boost Earnings Estimates for Ovid Therapeutics Inc. (NASDAQ:OVID)
ETF DAILY NEWS· 14 hours agoOvid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Equities research analysts at William Blair raised their Q2 2025 earnings per share estimates for shares ...
ViaSat (VSAT) Down 16.1% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 1 hour agoNotably, ViaSat has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next...
